🚀 VC round data is live in beta, check it out!
Pacific Edge Valuation Multiples
Discover revenue and EBITDA valuation multiples for Pacific Edge and similar public comparables like Alpha Teknova, 4basebio, ArcticZymes, SDI Group and more.
Pacific Edge Overview
About Pacific Edge
Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.
Founded
2001
HQ
Employees
122
Website
Sectors
Financials (LTM)
EV
$111M
Pacific Edge Financials
Pacific Edge reported last 12-month revenue of $8M and negative EBITDA of ($22M).
In the same LTM period, Pacific Edge generated $182K in gross profit, ($22M) in EBITDA losses, and had net loss of ($22M).
Revenue (LTM)
Pacific Edge P&L
In the most recent fiscal year, Pacific Edge reported revenue of $13M and EBITDA of ($17M).
Pacific Edge expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | $8M | XXX | $13M | XXX | XXX | XXX |
| Gross Profit | $182K | XXX | $13M | XXX | XXX | XXX |
| Gross Margin | 2% | XXX | 98% | XXX | XXX | XXX |
| EBITDA | ($22M) | XXX | ($17M) | XXX | XXX | XXX |
| EBITDA Margin | (285%) | XXX | (133%) | XXX | XXX | XXX |
| EBIT Margin | (292%) | XXX | (147%) | XXX | XXX | XXX |
| Net Profit | ($22M) | XXX | ($17M) | XXX | XXX | XXX |
| Net Margin | (284%) | XXX | (134%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Pacific Edge Stock Performance
Pacific Edge has current market cap of $122M, and enterprise value of $111M.
Market Cap Evolution
Pacific Edge's stock price is $0.12.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $111M | $122M | 0.0% | XXX | XXX | XXX | $-0.02 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialPacific Edge Valuation Multiples
Pacific Edge trades at 14.5x EV/Revenue multiple, and (5.1x) EV/EBITDA.
EV / Revenue (LTM)
Pacific Edge Financial Valuation Multiples
As of March 24, 2026, Pacific Edge has market cap of $122M and EV of $111M.
Equity research analysts estimate Pacific Edge's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Pacific Edge has a P/E ratio of (5.6x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $122M | XXX | $122M | XXX | XXX | XXX |
| EV (current) | $111M | XXX | $111M | XXX | XXX | XXX |
| EV/Revenue | 14.5x | XXX | 8.5x | XXX | XXX | XXX |
| EV/EBITDA | (5.1x) | XXX | (6.4x) | XXX | XXX | XXX |
| EV/EBIT | (5.0x) | XXX | (5.8x) | XXX | XXX | XXX |
| EV/Gross Profit | 608.5x | XXX | 8.7x | XXX | XXX | XXX |
| P/E | (5.6x) | XXX | (7.0x) | XXX | XXX | XXX |
| EV/FCF | (7.4x) | XXX | (7.4x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Pacific Edge Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Pacific Edge Margins & Growth Rates
Pacific Edge's revenue in the last 12 month grew by 9%.
Pacific Edge's revenue per employee in the last FY averaged $0.1M.
Pacific Edge's rule of 40 is (276%) (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Pacific Edge's rule of X is (263%) (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Pacific Edge Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 9% | XXX | (42%) | XXX | XXX | XXX |
| EBITDA Margin | (285%) | XXX | (133%) | XXX | XXX | XXX |
| EBITDA Growth | (35%) | XXX | 27% | XXX | XXX | XXX |
| Rule of 40 | — | XXX | (276%) | XXX | XXX | XXX |
| Bessemer Rule of X | — | XXX | (263%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | 126% | XXX | 78% | XXX | XXX | XXX |
| G&A Expenses to Revenue | 69% | XXX | 26% | XXX | XXX | XXX |
| R&D Expenses to Revenue | 106% | XXX | 66% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 250% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Pacific Edge Public Comps
See public comps and valuation multiples for other Life Sciences Tools comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Alpha Teknova | XXX | XXX | XXX | XXX | XXX | XXX |
| 4basebio | XXX | XXX | XXX | XXX | XXX | XXX |
| ArcticZymes | XXX | XXX | XXX | XXX | XXX | XXX |
| SDI Group | XXX | XXX | XXX | XXX | XXX | XXX |
| Insight Molecular | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Pacific Edge M&A Activity
Pacific Edge acquired XXX companies to date.
Last acquisition by Pacific Edge was on XXXXXXXX, XXXXX. Pacific Edge acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Pacific Edge
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialPacific Edge Investment Activity
Pacific Edge invested in XXX companies to date.
Pacific Edge made its latest investment on XXXXXXXX, XXXXX. Pacific Edge invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Pacific Edge
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Pacific Edge
| When was Pacific Edge founded? | Pacific Edge was founded in 2001. |
| Where is Pacific Edge headquartered? | Pacific Edge is headquartered in New Zealand. |
| How many employees does Pacific Edge have? | As of today, Pacific Edge has over 122 employees. |
| Is Pacific Edge publicly listed? | Yes, Pacific Edge is a public company listed on New Zealand Exchange. |
| What is the stock symbol of Pacific Edge? | Pacific Edge trades under PEB ticker. |
| When did Pacific Edge go public? | Pacific Edge went public in 2003. |
| Who are competitors of Pacific Edge? | Pacific Edge main competitors are Alpha Teknova, 4basebio, ArcticZymes, SDI Group. |
| What is the current market cap of Pacific Edge? | Pacific Edge's current market cap is $122M. |
| What is the current revenue of Pacific Edge? | Pacific Edge's last 12 months revenue is $8M. |
| What is the current revenue growth of Pacific Edge? | Pacific Edge revenue growth (NTM/LTM) is 9%. |
| What is the current EV/Revenue multiple of Pacific Edge? | Current revenue multiple of Pacific Edge is 14.5x. |
| Is Pacific Edge profitable? | No, Pacific Edge is not profitable. |
| What is the current EBITDA of Pacific Edge? | Pacific Edge has negative EBITDA and is not profitable. |
| What is Pacific Edge's EBITDA margin? | Pacific Edge's last 12 months EBITDA margin is (285%). |
| What is the current EV/EBITDA multiple of Pacific Edge? | Current EBITDA multiple of Pacific Edge is (5.1x). |
| What is the current FCF of Pacific Edge? | Pacific Edge's last 12 months FCF is ($15M). |
| What is Pacific Edge's FCF margin? | Pacific Edge's last 12 months FCF margin is (195%). |
| What is the current EV/FCF multiple of Pacific Edge? | Current FCF multiple of Pacific Edge is (7.4x). |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.